The incidence of pleural effusion in COVID-19 pneumonia: State-of-the-art review.
Heart Lung
; 50(4): 481-490, 2021.
Article
in English
| MEDLINE | ID: covidwho-1103928
ABSTRACT
BACKGROUND:
COVID-19-related pleural effusions are frequently described during the ongoing pandemic.OBJECTIVES:
We described the incidence, characteristics, and outcomes of COVID-19-related pleural effusions based on the current evidence available in the literature.METHODS:
We searched MEDLINE, Pubmed, and Google Scholar databases using keywords of "coronavirus disease 2019 (COVID-19)," "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)," "pleural effusion," "pleural fluid," and "pleura" from January 1st, 2020 to January 31st, 2021.RESULTS:
The incidence of pleural effusions was low at 7.3% among the 47 observational studies. Pleural effusions were commonly observed in critically ill patients and had Multisystem Inflammatory Syndrome (MIS). COVID-19-related pleural effusions were identified 5-7 days and 11 days, after hospital admission and onset of COVD-19 symptoms. The characteristic findings of pleural fluid were exudative, lymphocytic or neutrophilic-predominant pleural fluid with markedly elevated lactate dehydrogenase (LDH) levels and pleural fluid to serum LDH ratio.CONCLUSION:
A well-designed study is required to assess the significance of COVID-19-related pleural effusions during this current pandemic.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pleural Effusion
/
Pneumonia
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Reviews
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Heart Lung
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS